Physician profile
Anthony Smith
NPI 1134201031
$3,490.68
in general payments reported to CMS, 2019-2025
13 companies · $2,425 in 2025
The $2,425 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $318 · 2021: $368 · 2022: $160 · 2023: $84.99 · 2025: $2,425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,336 · Food and Beverage: $88.85 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,336.21 |
| Food and Beverage | $88.85 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $2,425.06 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.21 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $241.75 | 2020-2021 | |
| Insmed, INC. | $223.06 | 2021-2022 | |
| Glaxosmithkline, LLC. | $88.05 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $84.99 | 2023 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals Lp | $69.45 | 2020 | |
| Philips North America LLC | $39.51 | 2020 | |
| Janssen Pharmaceuticals, INC | $23.73 | 2021 | |
| Amgen INC. | $18.18 | 2021 | |
| Pfizer INC. | $14.42 | 2019 | |
| Lundbeck LLC | $12.27 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.